medline.ch Onkologie Haut

	Prognostic factors and treatment outcomes in female genital tract melanoma: a 10-year retrospective cohort study. World J Surg Oncol Mao M, Wang C, Yang W, Zuo Z, Liu B. PMID: 41761233 [PubMed - as supplied by publisher]
	Attenuated Salmonella as a PD-1/PD-L1 SiRNA delivery system for colorectal cancer, hepatocellular carcinoma, and melanoma: A systematic review. Curr Res Transl Med El-Kholy O, Guy M, Elsayed AAR, Basson MD. PMID: 41759482 [PubMed - as supplied by publisher]
	Unraveling the Enigma of Melanoma Brain Metastasis: New Molecular Insights and Therapeutic Directions. Int J Mol Sci O'Toole KT, Roan BM, Hardman TM, Phillips PP, VanBrocklin EM, Parkman GL, Holmen SL. PMID: 41752154 [PubMed - in process]
	Decoding the Role of Lipid Metabolism and Membrane Dynamics in Melanoma. Int J Mol Sci Pisanu ME, Iorio E, Facchiano F, Chirico M, Scattoni ML, Tabolacci C. PMID: 41751850 [PubMed - in process]
	Precision Oncology in Ocular Melanoma: Integrating Molecular and Liquid Biopsy Biomarkers. Curr Issues Mol Biol Ka, Gilevska F, Tomi, , Niku. PMID: 41751395 [PubMed]
	Survival Assessment by Central Review vs. Local Investigator in Metastatic Melanoma: A Systematic Review and Meta-Analysis. Cancers (Basel) Eljilany I, Jafari E, Alhumaid A, Eroglu Z, Brohl AS, Karapetyan L, Markowitz J, Khushalani NI, Hwu P, Tarhini AA. PMID: 41749963 [PubMed]
	Synthetic Melanoma Image Generation and Evaluation Using Generative Adversarial Networks. Bioengineering (Basel) Lin PY, Shen Y, Mathew N, Hu R, Huang S, Queen CM, West CE, Ciurea A, Zouridakis G. PMID: 41749783 [PubMed]
	Real-world data on anti-PD-1 plus lenvatinib as a treatment option in pretreated advanced melanoma patients - a retrospective DeCOG study. Eur J Cancer Albrecht LJ, Garnier J, Zaremba A, Brauch L, Brunnert F, Rauschenberg R, Forschner A, Vazquez XG, Mangana J, Erdmann M, Angela Y, Franklin C, Tietze J, Lodde G, Tasdogan A, Seier JA, Roesch A, Ugurel S, Berking C, Gutzmer R, Heinzerling L, Meier F, Mohr P, Hassel JC, Schadendorf D, Livingstone E, Zimmer L. PMID: 41747312 [PubMed - as supplied by publisher]
	Evaluation of Clinical Outcomes and Pattern of Recurrence in Patients with Cutaneous Melanoma and Sentinel Lymph Node Positivity Since the Publication of the MSLT-2 Trial. Ann Surg Oncol Mor E, Apte S, Bressel M, Broman KK, Hieken TJ, Olofsson Bagge R, Berman RS, Lee AY, Kuijpers AM, Ollila DW, van Akkooi ACJ, Zager JS, Gyorki DE. PMID: 41746574 [PubMed - as supplied by publisher]
	Tebentafusp-associated dermatological adverse events in patients with metastatic uveal melanoma: a single-center retrospective cohort study. Melanoma Res Zhou MH, Li W, Carpenter AK, Lipner SR. PMID: 41746214 [PubMed - in process]
	Cytokine Profiling in Cutaneous Melanoma: The Emerging Role of Interleukins in Prognostic Stratification with an Up-to-Date Overview of Published Data. J Pers Med Negoveti, Ga, Franceschi N, Buljan M. PMID: 41745410 [PubMed]
	Primary Clitoral Melanoma: Personalized Therapeutic Strategies Informed by Clinical Evidence and Systematic Review. J Pers Med Pitsillidi A, Vona L, Stabile G, Noé G. PMID: 41745363 [PubMed]
	Multimodality Imaging in Cardiac Metastasis of Cutaneous Melanoma: Case Report and Systematic Review. J Cardiovasc Dev Dis Lara-Sampayo KL, Ibarrola-Peña JC, de la Pena-Tamez M, Salinas-Casanova JA, Garcia R, Jerjes-Sanchez C, Paredes-Vazquez JG, de la Pena-Almaguer E. PMID: 41745331 [PubMed]
	Telomerase Activity in Melanoma: Impact on Cancer Cell Proliferation Kinetics, Tumor Progression, and Clinical Therapeutic Strategies-A Scoping Review. Curr Oncol Alqaisi O, Storme G, Dennis A, Dibas M, Sijarina L, Grabovci L, Al-Zghoul S, Yu E, Tai P. PMID: 41744838 [PubMed - in process]
	mRNA and Peptide Vaccines in Melanoma-Current Landscape and Future Direction. Cells Qin JJ, Wang Y, Sandhu S. PMID: 41744786 [PubMed - in process]
	Metastatic Melanoma Mimicking Primary Breast Cancer-A Diagnostic Challenge: A Case Report. Case Rep Pathol Rezende AS, Gutman TCF, Stumpf MVTC, Cunha KSG, Rodrigues FR, Lopes VGS. PMID: 41743380 [PubMed]
	Phenotypic, functional, prognostic and predictive significance of B-cell and antibody responses in human melanoma: A scoping review. Br J Dermatol Booth L, Chen X, Stoker K, McCraw A, Tahiri M, Wu Y, Geh JLC, MacKenzie Ross AD, Lloyd-Hughes H, Lacy KE, Whittaker S, Jacków-Malinowska J, Van Hemelrijck M, Tull TJ, Tsoka S, Karagiannis SN. PMID: 41742701 [PubMed - as supplied by publisher]
	Comparative Proteomic Analysis of the Secretome of Control and BRAF/MEK Inhibitor-Resistant Melanoma Cells. J Proteome Res Simiczyjew A, Surman M, Kot M, Przyby, Nowak D. PMID: 41742019 [PubMed - as supplied by publisher]
	Breaking Resistance in BRAF-Mutant Melanoma: Novel Strategies and Biomarkers for Optimizing Targeted Therapies. Eur J Pharmacol Al Hindawi MA, Omran NE, Mostafa MH, Alshihabi A, El-Gamal MI, Omar HA. PMID: 41740779 [PubMed - as supplied by publisher]
	Cost-effectiveness of sugemalimab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced oesophageal squamous cell carcinoma in China. BMJ Open Yan C, Li Z, Li J, Huang R, Li S, Diao R. PMID: 41734928 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 141588

Seite 1 von 7080

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung